Skip to main content
Clinical Trials/PACTR201907799024111
PACTR201907799024111
Not yet recruiting
Phase 2

Propofol versus Ketofol in Endoscopic retrograde cholangiopancreatography ERCP BIS guided sedation

ational liver institute0 sites80 target enrollmentJune 11, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational liver institute
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational liver institute

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 18 to 60 years undergoing ERCP
  • American Society of Anesthesiologists physical status class I\-II.

Exclusion Criteria

  • Patients with severe cardiovascular disease.
  • History of bronchial asthma.
  • Drug allergy to propofol or ketamine.
  • History of long term uptake of narcotics, benzodiazepine or any neuropsychiatric medication.
  • Pregnancy.
  • Obese patient with body mass index more than 36\.
  • History of any neurological insult.

Outcomes

Primary Outcomes

Not specified

Similar Trials